JPH1024103A - Membrane oxygenator - Google Patents

Membrane oxygenator

Info

Publication number
JPH1024103A
JPH1024103A JP18500596A JP18500596A JPH1024103A JP H1024103 A JPH1024103 A JP H1024103A JP 18500596 A JP18500596 A JP 18500596A JP 18500596 A JP18500596 A JP 18500596A JP H1024103 A JPH1024103 A JP H1024103A
Authority
JP
Japan
Prior art keywords
hollow fiber
membrane
blood
oxygenator
contact surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP18500596A
Other languages
Japanese (ja)
Inventor
Kojiro Ohara
康次郎 大原
Yoshiki Kuroaki
良樹 黒明
Soichi Tanaka
操一 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kuraray Co Ltd
Original Assignee
Kuraray Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuraray Co Ltd filed Critical Kuraray Co Ltd
Priority to JP18500596A priority Critical patent/JPH1024103A/en
Publication of JPH1024103A publication Critical patent/JPH1024103A/en
Pending legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)

Abstract

(57)【要約】 【課題】 中空糸を用いた外部潅流型の膜型人工肺にお
いて、長時間使用してもガス交換性能の低下をきたさな
い膜型人工肺を提供する。 【解決手段】 中空糸のガス接触面および血液接触面の
いずれも親水化処理する。
(57) [Problem] To provide a membrane-type artificial oxygenator using a hollow fiber, which does not cause a decrease in gas exchange performance even when used for a long time, in an external perfusion type membrane-type oxygenator. SOLUTION: Both the gas contact surface and the blood contact surface of the hollow fiber are subjected to a hydrophilic treatment.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は膜型人工肺に関す
る。詳しくは、中空糸を用いる外部潅流型の膜型人工肺
であって、該中空糸のガス接触面および血液接触面のい
ずれも親水化処理されている膜型人工肺に関する。
The present invention relates to a membrane oxygenator. More specifically, the present invention relates to an external perfusion type membrane oxygenator using a hollow fiber, wherein both the gas contact surface and the blood contact surface of the hollow fiber are subjected to a hydrophilic treatment.

【0002】[0002]

【従来の技術】人工肺は、生体肺の持つ機能の中で、血
液に酸素を富化し、二酸化炭素を除去するガス交換機能
を代行するものであって、開心術の補助手段として研究
・開発されており、現在気泡型人工肺と膜型人工肺が実
用化されている。
2. Description of the Related Art Among the functions of a living lung, an artificial lung substitutes a gas exchange function for enriching oxygen in blood and removing carbon dioxide, and is researched and developed as an auxiliary means for open heart surgery. At present, the bubble-type oxygenator and the membrane-type oxygenator are in practical use.

【0003】膜型人工肺は、膜を介して静脈血とガスと
を接触させ、静脈血の酸素濃度を高くすると同時に、ガ
ス中へ炭酸ガスを放出させるもので、気泡型人工肺に比
べてより生体肺に近く、血液損傷が少ない、プライミン
グボリウムが小さいなどの利点を有しており、臨床的に
頻繁に用いられるようになっている。
[0003] A membrane oxygenator is a technique in which venous blood is brought into contact with gas through a membrane to increase the oxygen concentration of venous blood and simultaneously release carbon dioxide into the gas. It has advantages such as being closer to a living lung, having less blood damage, and having a smaller priming volume, and has been frequently used clinically.

【0004】膜型人工肺の素材として使用されているポ
リマ−は、一般的には、ポリオレフィンなどの疎水性高
分子が殆どである。人工肺は、通常使用に先立って内部
の空気を除去するプライミング操作を行うが、プライミ
ング操作において、水とのなじみをよくする目的で、血
液との接触面である中空糸外部を親水化することが特公
平4−4906号公報に提案されている。
[0004] Generally, most of the polymers used as materials for the membrane-type oxygenator are hydrophobic polymers such as polyolefins. The artificial lung usually performs a priming operation to remove the internal air prior to use.However, in the priming operation, the outside of the hollow fiber that is the contact surface with blood is made hydrophilic to improve the familiarity with water. Has been proposed in Japanese Patent Publication No. 4-4906.

【0005】[0005]

【発明が解決しようとする課題】しかしながら、血液と
の接触面のみを親水化した場合、短時間の操作ではとく
に問題はないが、長時間にわたって使用し続けると、血
液中の水分が水蒸気として膜を通過し、中空糸内部で凝
縮して滞留する現象が見られる。中空糸内部に水分が滞
留すると、中空糸内部を流れるガスの通流に支障をきた
し、ガス交換性能が低下してくる。さらに2次的影響と
して、膜の親水化による血液中の有効成分の漏洩を生じ
る原因にもなる。したがって、本発明の目的は、ガスが
通流する中空糸内面に水が滞留することによるガス交換
性能低下のない膜型人工肺を提供することにある。
However, when only the contact surface with blood is hydrophilized, there is no particular problem in the operation in a short time, but if the device is used for a long time, the water in the blood is converted into water vapor as a film. , And condensed and stay inside the hollow fiber. If water stays inside the hollow fiber, the flow of gas flowing inside the hollow fiber is hindered, and the gas exchange performance is reduced. Further, as a secondary effect, it also causes leakage of active components in blood due to hydrophilicity of the membrane. Accordingly, an object of the present invention is to provide a membrane-type oxygenator in which gas does not deteriorate due to water remaining on the inner surface of a hollow fiber through which gas flows.

【0006】[0006]

【課題を解決するための手段】本発明者らは、上記目的
を達成するため鋭意検討を重ね、膜を透過した水蒸気が
血液とガスの温度差により凝縮し、凝縮した水滴が疎水
性の膜表面で接触角の小さい水滴を形成し、その水滴が
凝集、成長して中空糸内部のガスの流れを遮断すること
をつきとめ、中空糸のガス接触面および血液接触面のい
ずれも親水化処理をすれば、上記問題のない膜型人工肺
を得ることができることを見出だし、本発明に至った。
すなわち、本発明は、中空糸の中空部にガスを流し、中
空糸の外部に血液を流す外部潅流型の膜型人工肺におい
て、該中空糸のガス接触面および血液接触面のいずれも
親水化処理されていることを特徴とする膜型人工肺であ
る。
Means for Solving the Problems The present inventors have intensively studied to achieve the above object, and the water vapor that has permeated the membrane is condensed due to the temperature difference between blood and gas, and the condensed water droplets are converted to a hydrophobic membrane. A water droplet with a small contact angle is formed on the surface, and it is determined that the water droplet aggregates and grows to block the flow of gas inside the hollow fiber, and both the gas contact surface and the blood contact surface of the hollow fiber undergo hydrophilic treatment. Then, it was found that a membrane-type oxygenator free of the above problems could be obtained, and the present invention was achieved.
That is, the present invention relates to an external perfusion type membrane oxygenator in which gas flows in the hollow portion of a hollow fiber and blood flows outside the hollow fiber, and both the gas contact surface and the blood contact surface of the hollow fiber are hydrophilized. It is a membrane oxygenator characterized by being processed.

【0007】本発明に使用される中空糸膜の素材は、疎
水性のポリオレフィン系ポリマ−であればとくに限定は
なく、例えば、ポリ−4−メチルペンテン−1、ポリプ
ロピレン、ポリエチレンなどをあげることができる。中
空糸の外径は通常50〜2000μm、膜厚は3〜50
0μmである。外径や膜厚があまり小さいと、流体を流
す際の圧力損失が大きくなり、また、あまり大きいと、
装置のコンパクト性が実現しにくいので、中空糸の外径
は100〜500μm、膜厚は6〜100μmであるの
が好ましい。
The material of the hollow fiber membrane used in the present invention is not particularly limited as long as it is a hydrophobic polyolefin polymer, and examples thereof include poly-4-methylpentene-1, polypropylene and polyethylene. it can. The outer diameter of the hollow fiber is usually 50-2000 μm, and the film thickness is 3-50.
0 μm. If the outer diameter or the film thickness is too small, the pressure loss when flowing the fluid becomes large, and if it is too large,
Since it is difficult to realize compactness of the apparatus, the outer diameter of the hollow fiber is preferably 100 to 500 μm, and the film thickness is preferably 6 to 100 μm.

【0008】本発明においては、中空糸のガス接触面お
よび血液接触面のいずれも親水化処理することが重要で
ある。親水化処理方法としては、公知の方法を使用する
ことができ、例えば、硫酸系、塩酸系、燐酸系、塩素酸
系、p−トルエンスルフォン酸系、過マンガン酸カリウ
ム/硫酸、硫酸/クロム酸などの混合系などの酸化性酸
化合物処理やアルカリ処理、コロナ放電処理、プラズマ
処理、オゾン処理などを例示することができる。また、
ヘパリン化、アルブミンコ−ト、PHEMAコ−ト、M
PCコ−トなどの抗凝固性処理、グラフト重合、多層重
合なども有効である。
In the present invention, it is important that both the gas contact surface and the blood contact surface of the hollow fiber are subjected to a hydrophilic treatment. Known methods can be used for the hydrophilization treatment. For example, sulfuric acid, hydrochloric acid, phosphoric acid, chloric acid, p-toluenesulfonic acid, potassium permanganate / sulfuric acid, sulfuric acid / chromic acid can be used. Examples thereof include oxidizing acid compound treatment such as a mixed system, alkali treatment, corona discharge treatment, plasma treatment, and ozone treatment. Also,
Heparinization, albumin coat, PHEMA coat, M
Anticoagulation treatment such as PC coating, graft polymerization, multilayer polymerization and the like are also effective.

【0009】親水化されているか否かは、ハミルトンの
変法により、水中で膜と気泡の接触角度を測定すること
によって判定することができる。ハミルトンの変法と
は、ジャ−ナルオブコロイドアンドインタ−フェイスサ
イエンス第40巻第2号(Journal of Co
lloid and Interface Scien
ce,Vol.40,No.2,August 197
2,A Technique for the Cha
racterization of Hydrophi
lic Solid Surfaces,W.C.HA
MILTON)に記載された、水中における膜と気泡の
接触角度を測定する方法である。すなわち、親水化処理
前後のサンプルをハミルトンの変法に従って上記接触角
度を測定し、水との接触角がより小さくなっていれば、
親水化処理されていると判断することができる。
Whether or not the surface is hydrophilic can be determined by measuring the contact angle between the film and bubbles in water by a modified Hamilton method. Hamilton's modified method is described in Journal of Colloid and Interface Science, Vol. 40, No. 2 (Journal of Co.).
lloid and Interface Science
ce, Vol. 40, no. 2, August 197
2, A Technique for the Cha
rectification of Hydrophi
like Solid Solid Surfaces, W.C. C. HA
MILTON) is a method for measuring the contact angle between a film and bubbles in water. That is, the contact angle of the sample before and after the hydrophilic treatment is measured according to Hamilton's modified method, and if the contact angle with water is smaller,
It can be determined that a hydrophilic treatment has been performed.

【0010】本発明の人工肺は、中空糸の内外面ともに
親水化処理されているが、血液接触面である外面をさら
に抗血栓性材料で処理すると、血液接触面に抗血栓性が
付与されるので、好ましい。抗血栓性を付与するには、
親水化処理した外面を、必要に応じてイミン処理、シラ
ン処理した後、抗血栓性材料をコ−テイングすればよ
い。抗血栓性材料としては、入手の容易さ、価格の点な
どからヘパリンを使用するのが好ましい。
In the oxygenator of the present invention, both the inner and outer surfaces of the hollow fiber are subjected to hydrophilic treatment. However, when the outer surface, which is the blood contact surface, is further treated with an antithrombotic material, the blood contact surface is provided with antithrombotic properties. Therefore, it is preferable. To impart antithrombotic properties,
The outer surface subjected to the hydrophilic treatment may be subjected to an imine treatment and a silane treatment as necessary, and then coated with an antithrombotic material. As an antithrombotic material, it is preferable to use heparin from the viewpoint of availability and price.

【0011】[0011]

【発明の実施の形態】本発明の人工肺を得るには、ま
ず、公知の方法によって、例えばポリ−4−メチルペン
テン−1などのポリオレフィン系ポリマ−を膜素材とす
る中空糸を製造し、親水化処理する。親水化処理は上記
の公知の方法によればよい。
BEST MODE FOR CARRYING OUT THE INVENTION In order to obtain an artificial lung of the present invention, first, a hollow fiber using a polyolefin-based polymer such as poly-4-methylpentene-1 as a membrane material is produced by a known method. Perform hydrophilic treatment. The hydrophilic treatment may be performed according to the above-mentioned known method.

【0012】親水化の程度は、中空糸を適当な形状に加
工し、上述のハミルトンの変法により、水中における膜
と気泡の接触角度を測定する。本発明の効果の確認は、
人工肺性能評価基準(日本人工臓器協会)に従って、ヘ
モグロビン、ガス組成などを調整した牛血液を人工肺に
流し、人工肺の出入口の血液を採取して酸素及び炭酸ガ
スの移行量を測定することによって行う。
The degree of hydrophilicity is determined by processing a hollow fiber into an appropriate shape, and measuring the contact angle between a film and bubbles in water by the above-mentioned modified Hamilton method. Confirmation of the effect of the present invention,
In accordance with the artificial lung performance evaluation standard (Japan Society for Artificial Organs), bovine blood whose hemoglobin, gas composition, etc. has been adjusted is allowed to flow into the artificial lung, blood at the entrance and exit of the artificial lung is collected, and the amount of oxygen and carbon dioxide transferred is measured. Done by

【0013】[0013]

【実施例】【Example】

実施例1及び比較例1 内径250μm、外径300μmのポリプロピレン製の
中空糸を用いて膜面積1.8m2 の人工肺を作製した。
この人工肺の血液接触面(中空糸外面)及びガス流通部
分(中空糸内面)に0.8%過マンガン酸カリウム/2
0%硫酸水溶液を15分間灌流し、親水化処理した。親
水化処理は、中空糸外面及び中空糸内面を別々に行って
もよいが、0.8%過マンガン酸カリウム/20%硫酸
水溶液を中空糸外面に通過させ、連続して中空糸内面に
通過させれば一度に親水化処理することができる。
Example 1 and Comparative Example 1 Using a polypropylene hollow fiber having an inner diameter of 250 μm and an outer diameter of 300 μm, an artificial lung having a membrane area of 1.8 m 2 was produced.
0.8% potassium permanganate / 2 on the blood contact surface (hollow fiber outer surface) and gas flow part (hollow fiber inner surface) of this oxygenator
A 0% aqueous sulfuric acid solution was perfused for 15 minutes to perform a hydrophilic treatment. The hydrophilization treatment may be performed separately on the outer surface of the hollow fiber and the inner surface of the hollow fiber. However, a 0.8% potassium permanganate / 20% sulfuric acid aqueous solution is passed through the outer surface of the hollow fiber, and continuously passed through the inner surface of the hollow fiber. Then, the hydrophilic treatment can be performed at once.

【0014】親水化されていることは、エルマ光学株式
会社製のゴニオメ−タ−式接触角測定器(型式G−1)
を使用し、ハミルトンの変法により膜と気泡の接触角を
測定し、処理前に比べて接触角が小さくなっていること
で確認した。比較のために血液接触面のみ親水化処理し
た人工肺を作製した。
The hydrophilicity can be measured by using a goniometer-type contact angle measuring device (model G-1) manufactured by Elma Optical Co., Ltd.
Was used to measure the contact angle between the film and the bubbles by a modified Hamilton method, and it was confirmed that the contact angle was smaller than before the treatment. For comparison, an artificial lung in which only the blood contact surface was hydrophilized was prepared.

【0015】牛血液を、ヘモグロビンを12g/dl、
人工肺入口のガス組成を酸素飽和度(SvO2 )=55
%、炭酸ガス分圧(PCO2 )=45mmHg、ベ−ス
エクセス(BE)=0meq/lに調整した。内外面が
親水化された中空糸から構成された人工肺の中空糸外部
に該牛血液を6l/minで流し、中空糸の内側に10
0%の酸素ガスを6l/minで供給した[ガス流量
(V)/血液流量(Q)=1.0]。
[0015] Bovine blood, hemoglobin 12g / dl,
Oxygen saturation (SvO 2 ) = 55
%, Carbon dioxide partial pressure (PCO 2 ) = 45 mmHg, and base excess (BE) = 0 meq / l. The bovine blood flows at a rate of 6 l / min to the outside of the hollow fiber of the oxygenator, the inner and outer surfaces of which are made of a hollow fiber whose surface is made hydrophilic.
0% oxygen gas was supplied at 6 l / min [gas flow rate (V) / blood flow rate (Q) = 1.0].

【0016】人工肺の入口及び出口の血液を採取し、酸
素及び炭酸ガスの移行量を測定した。 血液接触面のみ
親水化処理した人工肺について同様にテストを行った。
酸素移行量及び炭酸ガス移行量を次の式(1)及び式
(2)により計算し、効果を確認した。360分におけ
るガス移行量の経時変化を図1に示す。
Blood was taken from the inlet and outlet of the oxygenator, and the amount of oxygen and carbon dioxide transferred was measured. The same test was performed for an artificial lung in which only the blood contact surface was hydrophilized.
The transfer amount of oxygen and the transfer amount of carbon dioxide were calculated by the following equations (1) and (2), and the effects were confirmed. FIG. 1 shows the change over time in the gas transfer amount at 360 minutes.

【0017】[0017]

【化1】 Embedded image

【0018】[0018]

【化2】 Embedded image

【0019】[0019]

【表1】 [Table 1]

【0020】[0020]

【表2】 [Table 2]

【0021】実施例2及び比較例2 内径205μm、外径255μmのポリ−4−メチルペ
ンテン−1製の中空糸を用いて膜面積2.2m2 の人工
肺を作製した。この人工肺のガス流通部分(中空糸内
面)に、0.8%過マンガン酸カリウム/20%硫酸水
溶液を15分間灌流し、親水化処理した。親水化の確認
は実施例1と同様に行った。
Example 2 and Comparative Example 2 Using a hollow fiber made of poly-4-methylpentene-1 having an inner diameter of 205 μm and an outer diameter of 255 μm, an artificial lung having a membrane area of 2.2 m 2 was prepared. A 0.8% potassium permanganate / 20% sulfuric acid aqueous solution was perfused through the gas flow portion (the inner surface of the hollow fiber) of the oxygenator for 15 minutes to perform a hydrophilic treatment. Confirmation of hydrophilicity was performed in the same manner as in Example 1.

【0022】血液接触面(中空糸外面)は、同様に親水
化処理した後、1%グリシドキシプロピルトリメトキシ
シラン水溶液を15分間灌流し、50℃で乾燥した。さ
らに、0.09%ポリエチレンイミン水溶液を2時間灌
流し、アルデヒド基を導入したヘパリン溶液を1.5時
間、3回灌流した後、水洗、乾燥した。比較のために、
血液接触面のみをヘパリン処理し、中空糸内面は親水化
処理しない人工肺を作製した。
The blood contact surface (the outer surface of the hollow fiber) was similarly subjected to a hydrophilic treatment, and then perfused with a 1% glycidoxypropyltrimethoxysilane aqueous solution for 15 minutes and dried at 50 ° C. Further, a 0.09% polyethyleneimine aqueous solution was perfused for 2 hours, and a heparin solution into which an aldehyde group was introduced was perfused three times for 1.5 hours, and then washed with water and dried. For comparison,
An artificial lung was prepared in which only the blood contact surface was treated with heparin and the inner surface of the hollow fiber was not hydrophilized.

【0023】実施例1と同様に、調整した牛血液を用い
て効果の確認を行った。360分におけるガス移行量の
経時変化を図2に示す。
In the same manner as in Example 1, the effect was confirmed using the adjusted bovine blood. FIG. 2 shows the change over time in the gas transfer amount at 360 minutes.

【0024】[0024]

【表3】 [Table 3]

【0025】[0025]

【表4】 [Table 4]

【0026】[0026]

【発明の効果】本発明によれば、中空糸の内外面を親水
化した膜型人工肺を提供することができる。本発明の膜
型人工肺は、血液中の水分が水蒸気として膜を通過して
も、中空糸内部で凝集して滞留することがない。したが
って、本発明の膜型人工肺は長時間使用してもガス交換
性能の低下をきたさず、極めて有用性が高い。
According to the present invention, it is possible to provide a membrane-type oxygenator in which the inner and outer surfaces of the hollow fiber are made hydrophilic. The membrane oxygenator of the present invention does not aggregate and stay inside the hollow fiber even when the water in the blood passes through the membrane as water vapor. Therefore, the membrane oxygenator of the present invention does not cause a decrease in gas exchange performance even when used for a long time, and is extremely useful.

【図面の簡単な説明】[Brief description of the drawings]

【図1】実施例1及び比較例1におけるガス移行量の経
時変化を示すグラフである。
FIG. 1 is a graph showing a change over time in a gas transfer amount in Example 1 and Comparative Example 1.

【図2】実施例2及び比較例2におけるガス移行量の経
時変化を示すグラフである。
FIG. 2 is a graph showing a change with time of a gas transfer amount in Example 2 and Comparative Example 2.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 中空糸の中空部にガスを流し、中空糸の
外部に血液を流す外部潅流型の膜型人工肺において、該
中空糸のガス接触面および血液接触面のいずれも親水化
処理されていることを特徴とする膜型人工肺。
1. An external perfusion type membrane oxygenator in which a gas flows through a hollow portion of a hollow fiber and a blood flows outside the hollow fiber, wherein both a gas contact surface and a blood contact surface of the hollow fiber are hydrophilized. A membrane oxygenator, which is characterized in that:
【請求項2】 血液接触面が、さらに抗血栓性材料で処
理されている請求項1記載の膜型人工肺。
2. The membrane oxygenator according to claim 1, wherein the blood contact surface is further treated with an antithrombotic material.
【請求項3】 該抗血栓性材料がヘパリンである請求項
2記載の膜型人工肺。
3. The membrane-type oxygenator according to claim 2, wherein said antithrombotic material is heparin.
JP18500596A 1996-07-15 1996-07-15 Membrane oxygenator Pending JPH1024103A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18500596A JPH1024103A (en) 1996-07-15 1996-07-15 Membrane oxygenator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18500596A JPH1024103A (en) 1996-07-15 1996-07-15 Membrane oxygenator

Publications (1)

Publication Number Publication Date
JPH1024103A true JPH1024103A (en) 1998-01-27

Family

ID=16163117

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18500596A Pending JPH1024103A (en) 1996-07-15 1996-07-15 Membrane oxygenator

Country Status (1)

Country Link
JP (1) JPH1024103A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009521981A (en) * 2005-12-29 2009-06-11 リクショスピタレット−ラディウムホスピタレット エイチエフ Method and apparatus for evaluating arterial oxygen partial pressure (PaO2) value in patients with extracorporeal circulation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009521981A (en) * 2005-12-29 2009-06-11 リクショスピタレット−ラディウムホスピタレット エイチエフ Method and apparatus for evaluating arterial oxygen partial pressure (PaO2) value in patients with extracorporeal circulation

Similar Documents

Publication Publication Date Title
EP0250337B1 (en) Semi-permeable hydrophilic polyvinylidene fluoride membranes suited for drying
EP0436447B1 (en) Asymmetric semipermeable membrane for the treatment of biological liquids
JPH0194901A (en) Permiation-selective unsymmetrical membrane suitable for blood dialysis
CN1921929A (en) High-flux dialysis membrane with an improved separation behavior
JPS5924732A (en) Hydrophilized porous membrane and its manufacturing method
JP4126062B2 (en) Hollow fiber membrane for blood purification and blood purification device using the same
FI94096C (en) Diaphragm for hemodialysis
JPH10225629A (en) Filter membrane and its production
JPH01104271A (en) Membrane type oxygenator
JPH10108907A (en) Membrane for hemocatharsis, its preparation and module for hemocatharsis
JP2000140589A (en) Porous polysulfone film
JP3714686B2 (en) Polysulfone-based hollow fiber membrane and method for producing the same
JPH1024103A (en) Membrane oxygenator
JPH07100201A (en) Membrane for purifying blood
JPH06296686A (en) Polysulfone hollow yarn membrane for medical purpose
JP3314861B2 (en) Hollow fiber membrane
Teber et al. Characterization and comparative evaluation of polysulfone and polypropylene hollow fiber membranes for blood oxygenators
JPS5944267A (en) Hollow yarn type artificial lung
JP3982906B2 (en) Blood processing membrane
JP4683402B2 (en) Hollow fiber membrane for blood purification, method for producing the same, and blood purifier
JP4190361B2 (en) Hollow fiber type body fluid treatment device, hollow fiber bundle used therefor, and method for producing them
JPH07289866A (en) Polysulfone-based selective permeable membrane
JP2004097918A (en) Polyetherimide conjugate hollow fiber membrane and its manufacturing method
JP2005058906A (en) Polymer porous membrane, blood purifier, and method for producing polymer porous membrane
JP4843993B2 (en) Blood purifier